You are about leaving the Roche Diagram website now.

Cancel

Advancing Care for Women through Cervical Cancer Prevention and Control

Cervical cancer prevention and control presents a unique opportunity to reduce the disease burden and improve women’s empowerment and participation in the economy.

Cervical cancer is one of the most common cancers affecting women worldwide, with more than 600,000 new cases and more than 340,000 deaths estimated in 2020. Approximately 70% of cervical cancer incidence and mortality occurs in Asia, the Latin American/Caribbean regions, and North America.1

Cervical cancer prevention and control presents a unique opportunity to not only significantly reduce the burden of this non-communicable disease (NCD), but to simultaneously improve women’s empowerment and participation in the economy. Effective cervical cancer control strategies exist along the cervical cancer control continuum, including primary prevention (human papillomavirus (HPV) vaccination), early detection and secondary prevention (e.g., screening, triage, treatment of precancerous lesions, treatment of women found to have invasive cancer, and symptom management/palliative care).2,3

The large number of interventions currently available and on the horizon can facilitate integration of cervical cancer prevention and management approaches into existing health systems across economies of many different resource levels and have a substantial impact on public health, the workforce, and the broader global economy.4 Furthermore, investments in cervical cancer prevention and control across the continuum, in line with WHO targets5, can simultaneously improve the health system’s ability to address other cancers and NCDs.

Cervical Cancer Prevention and Control
Cervical Cancer Prevention and Control
Cervical Cancer Prevention and Control
Cervical Cancer Prevention and Control
Cervical Cancer Prevention and Control

Download the roadmap here.

References:

1APEC Roadmap to Promote Sustainable Economic Advancement for Women Through Cervical Cancer Prevention and Control 2021-2025 (August, 2021) Retrieved from: http://mddb.apec.org/Documents/2021/MM/HLM-HE/21_hlm-he_004.pdf

 

You May Also Like

21 October 2022

Strengthening Healthcare Systems Through the Critical Role of Diagnostics

“Never waste a good crisis”. These words were first uttered nearly 100 years ago, and here we find ourselves in similar circumstances during the modern pandemic. While, certainly, COVID-19 has…

Read More
21 October 2022

Recommendations to Reduce Asia Pacific’s Patient Engagement Deficit

While the ability to engage with the world of healthcare is determined by the availability, accessibility, and efficiency of healthcare systems and infrastructure; people’s willingness to engage with the healthcare…

Read More
2 January 2023

Thriving, Not Just Surviving – Life as a Cervical Cancer Screening Advocate

Kirsty Browne shares her passion for being a cervical cancer screening advocate and her journey through battling this disease.

Read More

SHARE